Autoimmune hemolytic anemia during adalimumab treatment for plaque psoriasis.

@article{Harada2015AutoimmuneHA,
  title={Autoimmune hemolytic anemia during adalimumab treatment for plaque psoriasis.},
  author={Yukinori Harada and Hiroaki Yamamoto and Midori Sato and Mutsuki Kodaira and Tsunesuke Kono},
  journal={Internal medicine},
  year={2015},
  volume={54 9},
  pages={
          1103-4
        }
}
Adalimumab is commonly used to treat autoimmune diseases with few reported hematological adverse reactions. We herein describe the case of an 85-year-old Japanese man with plaque psoriasis who developed autoimmune hemolytic anemia (AIHA) after 3 years of adalimumab treatment. The patient suddenly developed hematuria and dyspnea on exertion while receiving adalimumab treatment. Laboratory data showed low hemoglobin levels and slightly increased reticulocyte counts, while direct and indirect… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-8 OF 8 REFERENCES

Similar Papers

Loading similar papers…